# Dapagliflozin

NDC: 67877-609
Generic name: Dapagliflozin
Labeler / Manufacturer: Ascend Laboratories, LLC
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: TABLET, FILM COATED
Routes: ORAL
Marketing started: 20260406

FDA application: ANDA211545

## Active ingredients

- DAPAGLIFLOZIN: 10 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"67877-609"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=67877-609
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=b6b8a10c-64c3-4856-8961-d72d68784f5d